Carcinoembryonic antigen (CEA) levels were determined in 742 postoperative patients with breast cancer. Within this group the percentage of elevated (24.0 ng/ml) assays increased with UICC clinical stage and was 14.8% (12/81), 23.7% (27/114), 73.1% (190/260) and 20.0% (49/245) for stages I, 11, 111,
Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress
โ Scribed by A. M. Steward; D. Nixon; N. Zamcheck; A. Aisenberg
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- English
- Weight
- 482 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Complement levels (CH,,, C,, C, and C1,) were determined in sera of 90 healthy subjects and 200 cancer patients. Complement levels of cancer patients were significantly higher than those of the healthy subjects, but there was a stagelinked increase of complement levels. Patients in remission had nea
Serum a(l + 3>L-fucosyltransferase activity was measured in 58 patients with lung cancer, 27 benign diseases, and in 100 healthy controls. The levels of enzyme activity were significantly higher in the sera of patients with cancer when compared to those in benign diseases and healthy controls. The e
## BACKGROUND. Clinicopathologic variables, carcinoembryonic antigen (CEA), nuclear DNA ploidy, and proliferating cell nuclear antigen labeling index (PCNA LI) have been studied for their effect on patients with various types of cancer. ## METHODS. Thirteen clinicopathologic variables, preoperati